 BEVERLY HILLS, Calif., Dec. 14, 2020 PRNewswire -- GT Biopharma, Inc. OTCQB: GTBP GTBP.PA an immuno-oncology company focused on innovative therapies based on the Companys proprietary NK cell engager TriKETM technology platform today announced that it has submitted an application... 